Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis

J Luebke; N Naumann; G Metzgeroth; S Kreil; T Brand; HP Horny; Karl Sotlar; NCP Cross; A Fabarius; P Valent; WK Hofmann; A Reiter; J Schwaab

doi:10.1007/s00277-023-05180-y

Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis

J Luebke, N Naumann, G Metzgeroth, S Kreil, T Brand, HP Horny, Karl Sotlar (Co-author), NCP Cross, A Fabarius, P Valent, WK Hofmann, A Reiter, J Schwaab

Institute of Pathology

Research output: Contribution to journal › Original Article › peer-review

6 Citations (Web of Science)

Original language	English
Journal	ANNALS OF HEMATOLOGY
DOIs	https://doi.org/10.1007/s00277-023-05180-y
Publication status	Published - 2023

Keywords

KIT D816V
MIDOSTAURIN
CLASSIFICATION
DIAGNOSIS
EFFICACY
THERAPY
SAFETY
MUTATIONS

Access to Document

10.1007/s00277-023-05180-y

Cite this

Luebke, J., Naumann, N., Metzgeroth, G., Kreil, S., Brand, T., Horny, HP., Sotlar, K., Cross, NCP., Fabarius, A., Valent, P., Hofmann, WK., Reiter, A., & Schwaab, J. (2023). Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis. ANNALS OF HEMATOLOGY https://doi.org/10.1007/s00277-023-05180-y

Luebke, J ; Naumann, N ; Metzgeroth, G et al. / Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis. In: ANNALS OF HEMATOLOGY 2023.

@article{c7aeffecfb994cec9cb5be347334f837,

title = "Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis",

keywords = "KIT D816V, MIDOSTAURIN, CLASSIFICATION, DIAGNOSIS, EFFICACY, THERAPY, SAFETY, MUTATIONS",

author = "J Luebke and N Naumann and G Metzgeroth and S Kreil and T Brand and HP Horny and Karl Sotlar and NCP Cross and A Fabarius and P Valent and WK Hofmann and A Reiter and J Schwaab",

note = "Sotlar: Department of Pathology, Paracelsus Medical Universityof Salzburg, Salzburg, Austria",

year = "2023",

doi = "10.1007/s00277-023-05180-y",

language = "English",

journal = "ANNALS OF HEMATOLOGY ",

issn = "0939-5555",

}

Luebke, J, Naumann, N, Metzgeroth, G, Kreil, S, Brand, T, Horny, HP, Sotlar, K, Cross, NCP, Fabarius, A, Valent, P, Hofmann, WK, Reiter, A & Schwaab, J 2023, 'Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis', ANNALS OF HEMATOLOGY https://doi.org/10.1007/s00277-023-05180-y

Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis. / Luebke, J; Naumann, N; Metzgeroth, G et al.
In: ANNALS OF HEMATOLOGY , 2023.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis

AU - Luebke, J

AU - Naumann, N

AU - Metzgeroth, G

AU - Kreil, S

AU - Brand, T

AU - Horny, HP

AU - Sotlar, Karl

AU - Cross, NCP

AU - Fabarius, A

AU - Valent, P

AU - Hofmann, WK

AU - Reiter, A

AU - Schwaab, J

N1 - Sotlar: Department of Pathology, Paracelsus Medical Universityof Salzburg, Salzburg, Austria

PY - 2023

Y1 - 2023

KW - KIT D816V

KW - MIDOSTAURIN

KW - CLASSIFICATION

KW - DIAGNOSIS

KW - EFFICACY

KW - THERAPY

KW - SAFETY

KW - MUTATIONS

U2 - 10.1007/s00277-023-05180-y

DO - 10.1007/s00277-023-05180-y

M3 - Original Article

C2 - 37012462

SN - 0939-5555

JO - ANNALS OF HEMATOLOGY

JF - ANNALS OF HEMATOLOGY

ER -

Luebke J, Naumann N, Metzgeroth G, Kreil S, Brand T, Horny HP et al. Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis. ANNALS OF HEMATOLOGY . 2023. doi: 10.1007/s00277-023-05180-y